Drugs for Neglected Diseases Initiative
The Drugs for Neglected Diseases initiative is a collaborative, patients' needs-driven, non-profit drug research and development organization that is developing new treatments for neglected diseases, notably leishmaniasis, sleeping sickness, Chagas disease, malaria, filarial diseases, mycetoma, paediatric HIV, cryptococcal meningitis, hepatitis C, and dengue. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Drugs for Neglected Diseases Initiative, Switzerland, covering academic research published from 2002 to 2023. Read More.
Open Access Percentage
83%
Total
Publications
650
Total Open
Publications
541
Total
Citations
24K
Open Access
Percentage
83%
Total
Publications
650
Total Open
Publications
541
Total
Citations
24K
Breakdown
Publisher Open
9%
Both
62%
Other Platform Open
12%
Closed
17%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 60%
274
Hybrid 29%
136
No Guarantees 11%
50
Other Platform Open
Domain 81%
391
Institution 46%
224
Public 14%
68
Other Internet 14%
68
Preprint 10%
50
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 390 |
Europe PMC | Domain | 249 |
Semantic Scholar | Public | 54 |
University of Oxford - Oxford University Research Archive (ORA) | Institution | 38 |
lshtm.ac.uk OAI-PMH Repository | Institution | 37 |
University College London - UCL Discovery | Institution | 34 |
Red Federada de Repositorios Institucionales de Publicaciones Científicas - LA Referencia | Other Internet | 32 |
London School of Hygiene and Tropical Medicine - LSHTM Research Online | Institution | 28 |
DOI | Other Internet | 24 |
University of Antwerp - Institutional Repository University of Antwerp | Institution | 19 |